Metabolic Syndrome in Rheumatoid Arthritis
Joint Authors
González-Juanatey, Carlos
Gonzalez-Gay, Miguel A.
Riancho-Zarrabeitia, Leyre
López-Mejías, Raquel
Ferraz-Amaro, Iván
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-01-30
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Insulin resistance is an essential feature of the metabolic syndrome that has been linked to rheumatoid arthritis (RA).
Understanding how inflammation arising in one tissue affects the physiology and pathology of other organs remains an unanswered question with therapeutic implications for chronic conditions including obesity, diabetes mellitus, atherosclerosis, and RA.
Adipokines may play a role in the development of atherogenesis in patients with RA.
Biologic therapies, such as TNF-α antagonists, that block proinflammatory cytokines have beneficial effects on the insulin resistance that is often observed in patients with RA.
American Psychological Association (APA)
Ferraz-Amaro, Iván& González-Juanatey, Carlos& López-Mejías, Raquel& Riancho-Zarrabeitia, Leyre& Gonzalez-Gay, Miguel A.. 2013. Metabolic Syndrome in Rheumatoid Arthritis. Mediators of Inflammation،Vol. 2013, no. 2013, pp.1-11.
https://search.emarefa.net/detail/BIM-492486
Modern Language Association (MLA)
Ferraz-Amaro, Iván…[et al.]. Metabolic Syndrome in Rheumatoid Arthritis. Mediators of Inflammation No. 2013 (2013), pp.1-11.
https://search.emarefa.net/detail/BIM-492486
American Medical Association (AMA)
Ferraz-Amaro, Iván& González-Juanatey, Carlos& López-Mejías, Raquel& Riancho-Zarrabeitia, Leyre& Gonzalez-Gay, Miguel A.. Metabolic Syndrome in Rheumatoid Arthritis. Mediators of Inflammation. 2013. Vol. 2013, no. 2013, pp.1-11.
https://search.emarefa.net/detail/BIM-492486
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-492486
